SCHEMBL31038211

SCHEMBL31038211

Cn1nccc1-c1cc(N2CCC(C=O)CC2)ncn1

nearest known ligand 0.46

Predicted protein targets (top 19)

geneUniProtsupporting neighboursconfidence
▸ LRRK2 Q5S007 9/20 0.46
▸ HRH4 Q9H3N8 1/20 0.40
▸ CYP1A2 P05177 8/20 0.39
▸ ALDH1A1 P00352 4/20 0.39
▸ HSD17B10 Q99714 2/20 0.39
▸ ALOX15 P16050 2/20 0.39
▸ KDM4E B2RXH2 1/20 0.39
▸ GLA P06280 1/20 0.39
▸ MAPT P10636 1/20 0.39
▸ HPGD P15428 1/20 0.39
▸ TSHR P16473 2/20 0.39
▸ CYP2C9 P11712 1/20 0.39
▸ MAPK1 P28482 1/20 0.39
▸ CYP2C19 P33261 2/20 0.37
▸ NPC1 O15118 1/20 0.36
▸ RECQL P46063 1/20 0.36
▸ RAB9A P51151 1/20 0.36
▸ SMN1; SMN2 Q16637 1/20 0.36
▸ ATR Q13535 1/20 0.35

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31038218 0.82 LRRK2 (0.51) LRRK2HRH4CYP1A2ALDH1A1HSD17B10
SCHEMBL25199948 0.82 LRRK2 (0.51) LRRK2HRH4CYP1A2ALDH1A1HSD17B10
SCHEMBL25559023 0.80 LRRK2 (0.45) LRRK2HRH4CYP1A2ALDH1A1HSD17B10
SCHEMBL31038219 0.80 KDM4E (0.50) LRRK2KDM4EMAPTSMN1; SMN2
SCHEMBL25188588 0.80 KDM4E (0.50) LRRK2KDM4EMAPTSMN1; SMN2
SCHEMBL25560002 0.74 SMO (0.37) MAPTSMN1; SMN2
SCHEMBL21452764 0.71 RPS6KB1 (0.45) HRH4CYP1A2ALDH1A1HSD17B10KDM4E
SCHEMBL31614476 0.71 OGA (0.38) HRH4CYP1A2ALOX15TSHRCYP2C19
SCHEMBL31205731 0.71 RIPK1 (0.48) LRRK2KDM4E
SCHEMBL31383394 0.70 CYP2C19 (0.58) HRH4CYP2C19

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-118510775-A Isoxazolidines as RIPK1 inhibitors and their use 建新公司 2024-08-16 — — CN claimed
CN-118510775-A Isoxazolidines as RIPK1 inhibitors and their use 建新公司 2024-08-16 — — CN disclosed
Send feedback